DUCTAL BREAST CARCINOMA IN SITU
Clinical trials for DUCTAL BREAST CARCINOMA IN SITU explained in plain language.
Never miss a new study
Get alerted when new DUCTAL BREAST CARCINOMA IN SITU trials appear
Sign up with your email to follow new studies for DUCTAL BREAST CARCINOMA IN SITU, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a week of radiation be enough? new study tests shorter breast cancer treatment
Disease control OngoingThis study tests whether a 1-week course of radiation after breast-conserving surgery works as well as the standard 3-week course for early-stage breast cancer. About 72 adults with ductal carcinoma in situ or early invasive breast cancer will be enrolled. The goal is to see if t…
Matched conditions: DUCTAL BREAST CARCINOMA IN SITU
Phase: NA • Sponsor: Coordinación de Investigación en Salud, Mexico • Aim: Disease control
Last updated May 26, 2026 05:05 UTC
-
Shorter radiation for breast cancer: fewer side effects?
Disease control TerminatedThis study tests a new way to give radiation to women with early-stage breast cancer. Instead of treating the whole breast, it targets only the area where the cancer started and uses higher doses over fewer sessions. The goal is to see if this approach causes fewer side effects w…
Matched conditions: DUCTAL BREAST CARCINOMA IN SITU
Phase: PHASE2, PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 05:04 UTC
-
Hunger training may cut breast cancer risk in obese women
Prevention OngoingThis pilot study looks at whether adding hunger training to a standard diabetes prevention program helps obese women at high risk for breast cancer lose weight and potentially lower their cancer risk. About 51 participants will learn weight-loss strategies and how to recognize tr…
Matched conditions: DUCTAL BREAST CARCINOMA IN SITU
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Prevention
Last updated May 22, 2026 13:54 UTC
-
Proton beam radiation: a gentler option for breast cancer?
Symptom relief OngoingThis study looks at how well proton beam radiation works for early-stage breast cancer (stages 0 to II) and what side effects it causes. Researchers want to see if this precise type of radiation can kill cancer cells while causing less damage to healthy tissue and improving how t…
Matched conditions: DUCTAL BREAST CARCINOMA IN SITU
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated May 26, 2026 05:06 UTC
-
Robots lend a hand in breast cancer surgery pilot
Symptom relief OngoingThis small pilot study tested whether a robot-assisted surgical system (da Vinci) can safely perform nipple-sparing mastectomy in 4 women with early-stage breast cancer or those needing preventive mastectomy. The goal was to see if the robot could remove breast tissue completely …
Matched conditions: DUCTAL BREAST CARCINOMA IN SITU
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Symptom relief
Last updated May 26, 2026 04:37 UTC
-
Shorter radiation may spare side effects for breast cancer patients
Symptom relief OngoingThis study tested whether a shorter course of higher-dose radiation (hypofractionated) works as well as standard longer radiation for early-stage breast cancer. About 300 women with ductal carcinoma in situ or early invasive breast cancer took part. The goal was to see if the sho…
Matched conditions: DUCTAL BREAST CARCINOMA IN SITU
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated May 19, 2026 11:48 UTC
-
New study uses MRI and gene tests to personalize DCIS treatment
Knowledge-focused OngoingThis study looks at whether combining MRI scans with genetic tests can help doctors choose the best treatment for people with ductal carcinoma in situ (DCIS), a very early form of breast cancer that hasn't spread. About 368 participants will be followed to see if MRI findings cha…
Matched conditions: DUCTAL BREAST CARCINOMA IN SITU
Phase: NA • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Knowledge-focused
Last updated May 26, 2026 04:36 UTC
-
Scientists investigate why breast cancer gel works differently in women
Knowledge-focused OngoingThis study looks at how a medicated gel (afimoxifene) is absorbed through the skin of the breast in women who have had radiation therapy for breast cancer. Researchers want to understand if skin type, blood vessels, or past radiation affect how much of the drug reaches breast tis…
Matched conditions: DUCTAL BREAST CARCINOMA IN SITU
Phase: PHASE2 • Sponsor: Northwestern University • Aim: Knowledge-focused
Last updated May 13, 2026 16:04 UTC